机器人手术治疗小肠神经内分泌肿瘤较腹腔镜清扫更多淋巴结
基于美国国家癌症数据库2015至2022年I-III期小肠神经内分泌肿瘤患者数据,分析机器人手术与腹腔镜手术的淋巴结清扫及生存差异。倾向性匹配后机器人手术淋巴结清扫中位数17枚,高于腹腔镜的14枚,且达到≥9枚清扫阈值的可能性更高(aOR 2.09),该阈值与5年死亡率降低相关(aHR 0.696)。
要点
- 机器人手术治疗I-III期小肠神经内分泌肿瘤的淋巴结清扫数量多于腹腔镜(中位17 vs 14枚)。
核心结论
- 对于I-III期小肠神经内分泌肿瘤,机器人手术较腹腔镜清扫更多淋巴结,并更可能达到≥9枚的淋巴结清扫阈值,该阈值与总生存改善相关。
研究设计与样本
- 回顾性队列研究,查询美国国家癌症数据库2015至2022年因I-III期小肠神经内分泌肿瘤行机器人或腹腔镜手术的患者,共5432例 eligible,其中1066例(19.6%)接受机器人手术。
关键数值与推荐
- adequate淋巴结清扫定义为切除≥9枚淋巴结。
临床怎么用
- 在适当选择的可切除小肠神经内分泌肿瘤患者中,机器人手术可能提供技术和肿瘤学优势,应致力于达到至少9枚淋巴结的清扫。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Robotic surgery has been increasingly used for the treatment of small bowel neuroendocrine tumors and offers potential advantages in visualization of nodal disease and mesenteric dissection compared to laparoscopy; however, oncologic outcomes of robotic surgery have not yet been characterized. We sought to compare lymph node harvest of robotic surgery versus laparoscopy and associated long-term survival for small bowel neuroendocrine tumors using a large national cohort. METHODS: The National Cancer Database was queried for patients who underwent robotic surgery/laparoscopy for stage I-III small bowel neuroendocrine tumors from 2015 to 2022. Kaplan-Meier and multivariable Cox proportional hazards analyses were used to assess overall survival. Multivariable logistic regression was used to identify factors associated with adequate lymph node harvest (defined as ≥9 nodes resected). RESULTS: Of 5,432 eligible patients, 1,066 (19.6%) underwent robotic surgery. After propensity-matching, robotic surgery was associated with greater lymph node harvest versus laparoscopy (median 17 vs 14 nodes, P < .001) and improvement in select short-term perioperative outcomes. On Cox proportional hazards analysis, the threshold lymph node harvest of ≥9 nodes was associated with the greatest 5-year mortality reduction (adjusted hazard ratio: 0.696, P = .002). On multivariable logistic regression, undergoing robotic surgery was associated with increased likelihood of achieving lymph node harvest of ≥9, even when controlling for tumor characteristics/location (adjusted odds ratio: 2.09, P < .001). CONCLUSION: Robotic surgery was associated with greater lymph node harvest in patients with stage I-III small bowel neuroendocrine tumors compared to laparoscopy. Patients with ≥9 nodes harvested exhibited improved overall survival , and robotic surgery was significantly associated with achievement of this threshold. Robotic surgery may offer technical and oncologic advantages over laparoscopy in appropriately selected patients with resectable small bowel neuroendocrine tumors.
引用
- Farooq MS, Vargas GM, Simons RA, et al. Robotic surgery for small bowel neuroendocrine tumors is associated with greater nodal harvest compared to laparoscopic surgery. Surgery. 2026. PMID: 41924796. doi:10.1016/j.surg.2026.110165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。